|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hepatitis C virus infection and type 1 and type 2 diabetes mellitus显示文摘Hepatitis C virus(HCV) infection and diabetes mellitus are two major public health problems that cause devastating health and financial burdens worldwide. Diabetes can be classified into two major types: type 1 diabetes mellitus(T1DM) and T2 DM. T2 DM is a common endocrine disorder that encompasses multifactorial mechanisms, and T1 DM is an immunologically mediated disease. Many epidemiological studies have shown an association between T2 DM and chronic hepatitis C(CHC) infection. The processes through which CHC is associated with T2 DM seem to involve direct viral effects, insulin resistance, proinflammatory cytokines, chemokines, and other immunemediated mechanisms. Few data have been reported on the association of CHC and T1 DM and reports on the potential association between T1 DM and acute HCV infection are even rarer. A small number of studies indicate that interferon-α therapy can stimulate pancreatic autoim-munity and in certain cases lead to the development of T1 DM. Diabetes and CHC have important interactions. Diabetic CHC patients have an increased risk of developing cirrhosis and hepatocellular carcinoma compared with nondiabetic CHC subjects. However, clinical trials on HCV-positive patients have reported improvements in glucose metabolism after antiviral treatment. Further studies are needed to improve prevention policies and to foster adequate and cost-effec-tive programmes for the surveillance and treatment of diabetic CHC patients. | Alessandro Antonelli Silvia Martina Ferrari Dilia Giuggioli Andrea Di Domenicantonio Ilaria Ruffilli Alda Corrado Silvia Fabiani Santino Marchi Clodoveo Ferri Ele Ferrannini Poupak Fallahi | 2014 | World Journal of Diabetes2014，5，5： | 7 |
| 2 | Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R | 2012 | EN2012，，3： | 6 |
| 3 | 苯甲酸钠诱发可重复的急性荨麻疹/血管性水肿:随机对照试验 | Nettis E. Colanardi M.C. Ferrannini A. Tursi A. 党倩丽 | 2005 | 世界核心医学期刊文摘(皮肤病学分册)2005，0，3： | 4 |
| 4 | 高血压与糖尿病:共同发展与时间轨迹研究显示文摘在人群中2型糖尿病与高血压常合并存在。许多个体糖尿病的发展特点是血浆葡萄糖值的相对快速升高。高血压的发展是否存在相似的现象仍不明确。该研究采用来自墨西哥城糖尿病研究(Mexico city diabetes study,MCDS;一个基于西班牙裔白人的糖尿病人群研究)及Framingham后代研究(Framingham offspring study,FOS;一个基于社区的非西班牙裔白人研究)的7年随访数据,分析未合并或合并糖尿病的患者高血压发展过程中的血压变化模式。 | 赵狄 练桂丽 Tsimihodimos V Gonzalez-Villalpando C Meigs JB Ferrannini E | 2018 | 中华高血压杂志2018，26，1： | 3 |
| 5 | Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms显示文摘 | E. Bugianesi A. Gastaldelli E. Vanni R. Gambino M. Cassader S. Baldi V. Ponti G. Pagano E. Ferrannini M. Rizzetto | 2005 | Diabetologia2005，，4： | 3 |
| 6 | ADA与EASD对2型糖尿病高血糖处理:治疗启动与评定的新共识方案显示文摘在不到一年时间由同一批专家代表ADA和EASD先后起草和发布了两次关于'2型糖尿病高血糖处理的共识声明'同时发表在2008年1月和12月的《Diabetes Care》和《Diabetologia》上。第一次共识声明内容主要围绕TZDs药物的安全性,本刊作了摘译转载(参阅《中国糖尿病杂志》2008年第7期)。第二次修订的共识声明,关注点为降糖药的新分级,论据及观点比较清晰,故仍摘译供读者参考。 | Nathan DM Buse JB Davidson MB Ferrannini E Holman RR Sherwin R Zinman B 钱荣立(摘译) | 2009 | 中国糖尿病杂志2009，17，1： | 2 |
| 7 | Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | S. E. Inzucchi R. M. Bergenstal J. B. Buse M. Diamant E. Ferrannini M. Nauck A. L. Peters A. Tsapas R. Wender D. R. Matthews | 2012 | Diabetologia2012，，6： | 2 |
| 8 | The metabolic syndrome:time for a criticaL appraisal:joint statement from the American Diabetes Association and the European Association for the Study of Diabetes 显示文摘 | Kahn R Buse J Ferrannini E | 2005 | Diabetes Care2005，28，9： | 1 |
| 9 | Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism ( SAM ) study 显示文摘 | GASTALDELLI A FERRANNINI E MIYAZAKI Y | 2004 | Diabetologia2004，47，1： | 1 |
| 10 | Insulin resistance a multifaced syndrome responsible for NDDM,obesity,hypertension,dyslip idemia,and atherosclerotic cardioras culardisease显示文摘 | Defrenzo RA Ferrannini E | 1991 | Diabetes Care1991，14，3： | 1 |
| 11 | Insulin resistance, iron, and the liver显示文摘 | Ferrannini E L E | 2000 | Lancet2000，355，： | 1 |
| 12 | Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study 显示文摘 | FERRANNINI E MASSARI M NANNIPIERI M | 2009 | Diabetologia2009，52，5： | 1 |
| 13 | Association of fasting glucagon and proinsulin concentrations with insulin resistance显示文摘 | Ferrannini E Muscelli E Natali A | 2007 | Diabetologia2007，50，11： | 1 |
| 14 | Canagliflozin,a Sodium glucose co-transporter 2 inhibitor,improves model-based indices of beta cell function in patients with type 2 diabetes显示文摘 | Polidori D Mari A Ferrannini E | 2014 | Diabetologia2014，57，5： | 1 |
| 15 | Dapagliflozinmonotherapy in type 2 diabetic patients with inadequateglycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial 显示文摘 | Ferrannini E Ramos SJ Salsali A | 2010 | Diabetes Care2010，33，10： | 1 |
| 16 | Essential hypertension: an insulin-resistant state显示文摘 | Ferrannini E Haffner SM Stern MP | 1990 | J Cardiovasc Pharmacol1990，15，5： | 1 |
| 17 | Hyperinsulinaemia:the key feature of a cardiovascular and metabolic syndrome显示文摘 | Haffner SM Mitchell BD | 1991 | Diabetologia1991，40，： | 1 |
| 18 | Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise : a randomized, double-blind, placebo-controlled, phase 3 trial 显示文摘 | Ferrannini E Ramos S J | 2010 | Diabetes Care2010，10，： | 1 |
| 19 | The metabolic syndrome for a critical appraisal:joint statement from the American Diabetes Association and the European Association for the Study of Diabetes 显示文摘 | Kahn R Buse J Ferrannini E | 2005 | Diabetes Care2005，28，9： | 1 |
| 20 | Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance显示文摘 | Ferrannini E Gastaldelli A Miyazaki Y | 2003 | Diabetologia2003，46，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员